BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Genetown

  PLC Systems, Inc. Announces Approval of First European Study to Evaluate RenalGuard(TM) Trial Designed to Evaluate Effectiveness of Device in Preventing Contrast-Induced Nephropathy

  June 3, 2008

   · 

  6 min read
• Drug Development

  Emory University Study: Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

  June 3, 2008

   · 

  4 min read
• Business

  AXSUN Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging

  June 3, 2008

   · 

  2 min read
• Drug Development

  ANTISENSE PHARMA GmbH Release: Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma

  June 3, 2008

   · 

  4 min read
• Drug Development

  Cell Therapeutics, Inc. Release: Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin’s Lymphoma

  June 3, 2008

   · 

  5 min read
• Biotech Beach

  Boehringer Ingelheim Corporation, Gilead Sciences, Inc. Agree to AIDS Drug Price Freeze

  June 3, 2008

   · 

  4 min read
• CSL Behring Awards Global Grants to Next Generation of Coagulation Researchers

  June 3, 2008

   · 

  1 min read
• Drug Development

  Cell Therapeutics, Inc. Release: Paclitaxel Poliglumex (OPAXIO(TM))/Capecitabine Regimen Well Tolerated And Active In Metastatic Breast Cancer; Results Of Phase II Investigator-Sponsored Trial Presented At American Society of Clinical Oncology Show Invest

  June 3, 2008

   · 

  4 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Phase 2 Results On KRX-0401 (Perifosine) In Patients With Relapsed/Refractory Waldenstroms Macroglobulinemia At The 44th Annual Meeting Of The American Society of Clinical Oncology

  June 3, 2008

   · 

  7 min read
• Business

  Following Positive Results Vivalis and Bavarian Nordic Extend the EBx(R) Research Licence

  June 3, 2008

   · 

  1 min read